Abiraterone acetate for castration resistant prostate cancer.
about
Androgen receptors beyond prostate cancer: an old marker as a new target.The complex interplay between cholesterol and prostate malignancy.From clinical trials to clinical practice: therapeutic cancer vaccines for the treatment of prostate cancerAndrogen regulation of prostate cancer: where are we now?Androgen suppression strategies for prostate cancer: is there an ideal approach?Chemotherapy for prostate cancer: when should a urologist refer a patient to a medical oncologist?
P2860
Abiraterone acetate for castration resistant prostate cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Abiraterone acetate for castration resistant prostate cancer.
@en
Abiraterone acetate for castration resistant prostate cancer.
@nl
type
label
Abiraterone acetate for castration resistant prostate cancer.
@en
Abiraterone acetate for castration resistant prostate cancer.
@nl
prefLabel
Abiraterone acetate for castration resistant prostate cancer.
@en
Abiraterone acetate for castration resistant prostate cancer.
@nl
P2860
P1476
Abiraterone acetate for castration resistant prostate cancer.
@en
P2093
Charles Ryan
Shreya Shah
P2860
P304
P356
10.1517/13543781003639427
P407
P577
2010-04-01T00:00:00Z